Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMID 12943894)

Published in Am J Cardiol on September 01, 2003

Authors

Alan H B Wu1, Andrew Smith, Stacey Wieczorek, Jeffrey F Mather, Bret Duncan, C Michael White, Carol McGill, Deb Katten, Gary Heller

Author Affiliations

1: Department of Pathology and Laboratory Medicine, Hartford Hospital, Hartford, Connecticut 06102, USA. awu@harthosp.org

Articles citing this

Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol (2006) 1.98

Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure. Circ Heart Fail (2011) 1.19

Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions. Heart Fail Rev (2007) 1.16

The future of laboratory medicine: understanding the new pressures. Clin Biochem Rev (2004) 1.16

In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study. Crit Care (2010) 1.04

What is treatment success in cardiac resynchronization therapy? Europace (2009) 1.02

Reference limits for N-terminal-pro-B-type natriuretic peptide in healthy individuals (from the Framingham Heart Study). Am J Cardiol (2011) 1.00

Prognostic significance of blood pressure response to exercise in patients with systolic heart failure. Heart Vessels (2011) 0.91

A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension. Clin Pharmacol Ther (2009) 0.87

Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study. Heart (2007) 0.86

Elevated B-type natriuretic peptide level as a marker of subsequent thromboembolic events in patients with atrial fibrillation. Heart Vessels (2010) 0.85

Usefulness of soluble endoglin as a noninvasive measure of left ventricular filling pressure in heart failure. Am J Cardiol (2010) 0.85

Effects of ambient air pollution on functional status in patients with chronic congestive heart failure: a repeated-measures study. Environ Health (2007) 0.83

Variability of NT-proBNP and its relationship with inflammatory status in patients with stable essential hypertension: a 2-year follow-up study. PLoS One (2012) 0.83

B-type natriuretic peptides for the prediction of cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study. J Am Heart Assoc (2014) 0.82

Effect of stress-induced reversible ischemia on serum concentrations of ischemia-modified albumin, natriuretic peptides and placental growth factor. Clin Res Cardiol (2006) 0.81

Variability of NT-proBNP levels in heart failure: implications for clinical application. Heart (2007) 0.81

Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy. Eur Heart J (2009) 0.80

Brain type natriuretic peptide (BNP)-A marker of new millennium in diagnosis of congestive heart failure. Indian J Clin Biochem (2007) 0.80

N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients. Clin J Am Soc Nephrol (2015) 0.79

Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure : a clinical review. Heart Fail Rev (2006) 0.79

Multi-Marker Strategy in Heart Failure: Combination of ST2 and CRP Predicts Poor Outcome. PLoS One (2016) 0.78

Steady-state B-type natriuretic peptide levels in patients with atrial fibrillation of various clinical backgrounds. Heart Vessels (2011) 0.77

Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy? Clin Res Cardiol (2011) 0.77

NT-ProBNP levels, water and sodium homeostasis in healthy men: effects of 7 days of dry immersion. Eur J Appl Physiol (2011) 0.76

The biological variation of N-terminal pro-brain natriuretic peptide in postmenopausal women with type 2 diabetes: a case control study. PLoS One (2012) 0.76

Induction of early biomarkers in a thrombus-induced sheep model of ischemic heart failure. Tex Heart Inst J (2013) 0.76

N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency. PLoS One (2014) 0.76

[Differential diagnosis of dyspnea - significance of clinic aspects, imaging and biomarkers for the diagnosis of heart failure]. Clin Res Cardiol (2006) 0.75

Plasma B-type natriuretic peptide levels are poorly related to the occurrence of ischemia or ventricular arrhythmias during symptom-limited exercise in low-risk patients. Arch Med Sci (2016) 0.75

National Academy of Clinical Biochemistry (NACB) laboratory medicine guidelines on the clinical utilization and analytical issues for cardiac biomarker testing in heart failure. Clin Biochem Rev (2008) 0.75

Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis. Leukemia (2016) 0.75

N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma. Am J Hematol (2016) 0.75

Proceedings of the 10th Asian Pacific Congress of Clinical Biochemistry in conjunction with the Australasian Association of Clinical Biochemists' 42nd Annual Scientific Conference. Clin Biochem Rev (2004) 0.75

Determining Nt-proBNP Levels with Diastolic Dysfunction in Thalassemia Major Patients. J Pediatr Genet (2017) 0.75

Relevance of short-term variation of B-type natriuretic peptide in patients with clinically stable heart failure. Wien Klin Wochenschr (2008) 0.75

Articles by these authors

Statins and cancer risk: a meta-analysis. JAMA (2006) 6.28

Reversal of the TCR stop signal by CTLA-4. Science (2006) 4.59

Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol (2013) 4.04

Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. JAMA (2004) 2.86

Effect of statins on skeletal muscle function. Circulation (2012) 2.54

Number and impact of published scholarly works by pharmacy practice faculty members at accredited US colleges and schools of pharmacy (2001-2003). Am J Pharm Educ (2007) 2.36

Neurothrombectomy devices for the treatment of acute ischemic stroke: state of the evidence. Ann Intern Med (2011) 2.28

Impact of statin dosing intensity on transaminase and creatine kinase. Am J Med (2007) 2.15

SARS among critical care nurses, Toronto. Emerg Infect Dis (2004) 2.10

Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis (2007) 1.87

YeastHub: a semantic web use case for integrating data in the life sciences domain. Bioinformatics (2005) 1.82

The maize methylome influences mRNA splice sites and reveals widespread paramutation-like switches guided by small RNA. Genome Res (2013) 1.78

Preoperative evaluation of the adult patient undergoing non-cardiac surgery: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol (2011) 1.74

Parasite zoonoses and wildlife: emerging issues. Int J Environ Res Public Health (2009) 1.67

Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging. J Am Coll Cardiol (2003) 1.65

Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol (2015) 1.64

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease. Ann Intern Med (2009) 1.62

Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol (2011) 1.62

A transition probability model for amino acid substitutions from blocks. J Comput Biol (2003) 1.61

Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering. Hypertension (2008) 1.60

Endogenous cardiac stem cell activation by insulin-like growth factor-1/hepatocyte growth factor intracoronary injection fosters survival and regeneration of the infarcted pig heart. J Am Coll Cardiol (2011) 1.58

Mining the structural genomics pipeline: identification of protein properties that affect high-throughput experimental analysis. J Mol Biol (2004) 1.57

Attenuation artifact, attenuation correction, and the future of myocardial perfusion SPECT. J Nucl Cardiol (2007) 1.57

Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. J Thorac Cardiovasc Surg (2008) 1.55

Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations. Pharmacogenomics (2008) 1.50

Effect of intravenous testosterone on myocardial ischemia in men with coronary artery disease. Am Heart J (2002) 1.49

Sensitivity to biases of case-control studies on medical procedures, particularly surgery and blood transfusion, and risk of Creutzfeldt-Jakob disease. Neuroepidemiology (2012) 1.47

Fractalkine-induced activation of the phosphatidylinositol-3 kinase pathway attentuates microglial activation in vivo and in vitro. J Neurochem (2009) 1.45

Almonds have a neutral effect on serum lipid profiles: a meta-analysis of randomized trials. J Am Diet Assoc (2009) 1.44

Pyrocarbon implant fracture after metacarpophalangeal joint arthroplasty: an unusual cause for early revision. J Hand Surg Eur Vol (2010) 1.42

Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis. Diabetes Res Clin Pract (2009) 1.42

Association between statin use and mortality in patients with implantable cardioverter-defibrillators and left ventricular systolic dysfunction. Heart Rhythm (2007) 1.42

The renal protective effects of angiotensin II receptor blockers in type 2 diabetes mellitus. Ann Pharmacother (2004) 1.41

SKAP-55 regulates integrin adhesion and formation of T cell-APC conjugates. Nat Immunol (2003) 1.41

Effect of nonergot dopamine agonists on symptoms of restless legs syndrome. Ann Fam Med (2008) 1.41

Prasugrel: a critical comparison with clopidogrel. Pharmacotherapy (2009) 1.41

Are the risk factors listed in warfarin prescribing information associated with anticoagulation-related bleeding? A systematic literature review. Int J Clin Pract (2011) 1.41

Cowpox virus infection in natural field vole Microtus agrestis populations: significant negative impacts on survival. J Anim Ecol (2008) 1.41

Intermediate-affinity LFA-1 binds alpha-actinin-1 to control migration at the leading edge of the T cell. EMBO J (2007) 1.39

Multi-center determination of galectin-3 assay performance characteristics: Anatomy of a novel assay for use in heart failure. Clin Biochem (2010) 1.38

Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter. Ann Pharmacother (2007) 1.38

Importance of integrin LFA-1 deactivation for the generation of immune responses. J Exp Med (2005) 1.37

Cortical ependymoma or monomorphous angiocentric glioma? Neuropathology (2007) 1.35

Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials. J Hypertens (2008) 1.35

Physiogenomic association of statin-related myalgia to serotonin receptors. Muscle Nerve (2007) 1.35

Understanding heterogeneity in meta-analysis: the role of meta-regression. Int J Clin Pract (2009) 1.34

Detection of large numbers of pneumococcal virulence genes in streptococci of the mitis group. J Clin Microbiol (2010) 1.32

Fish consumption, advisory awareness, and hair mercury levels among women of childbearing age. Environ Res (2005) 1.30

Genetic analysis of diverse disease-causing pneumococci indicates high levels of diversity within serotypes and capsule switching. J Clin Microbiol (2004) 1.29

Genomic diversity between strains of the same serotype and multilocus sequence type among pneumococcal clinical isolates. Infect Immun (2006) 1.27

2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: synthesis, in vitro SAR, protein crystallography, and in vivo activity. J Med Chem (2006) 1.25

CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system. J Card Fail (2011) 1.24

Signaling through integrin LFA-1 leads to filamentous actin polymerization and remodeling, resulting in enhanced T cell adhesion. J Immunol (2002) 1.24

Assessment of 100 live potential renal donors for laparoscopic nephrectomy with multi-detector row helical CT. Radiology (2005) 1.23

The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care (2005) 1.22

A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design. Prev Cardiol (2010) 1.21

Tranexamic acid is associated with less blood transfusion in off-pump coronary artery bypass graft surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth (2010) 1.21

Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin. J Clin Microbiol (2006) 1.18

The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials. Curr Med Res Opin (2008) 1.18

Effect of cinnamon on glucose control and lipid parameters. Diabetes Care (2007) 1.17

Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks. J Infect Dis (2007) 1.16

The effects of barley-derived soluble fiber on serum lipids. Ann Fam Med (2009) 1.15

Cowpox virus infection in natural field vole Microtus agrestis populations: delayed density dependence and individual risk. J Anim Ecol (2006) 1.15

Hearing impairment and socioeconomic factors: a population-based survey of an urban locality in southern Brazil. Rev Panam Salud Publica (2007) 1.15

How T cells use LFA-1 to attach and migrate. Immunol Lett (2004) 1.15

Conversations between carers and people with schizophrenia: a qualitative analysis using leximancer. Qual Health Res (2010) 1.14

Postoperative atrial fibrillation - what do we really know? Curr Vasc Pharmacol (2010) 1.14

Factors affecting incidence of dry socket: a prospective community-based study. J Oral Maxillofac Surg (2011) 1.12

Sex differences in age-related stiffening of the aorta in subjects with type 2 diabetes. Hypertension (2004) 1.11

Novel non-steroidal inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. J Steroid Biochem Mol Biol (2007) 1.10

Physiogenomic analysis links serum creatine kinase activities during statin therapy to vascular smooth muscle homeostasis. Pharmacogenomics (2005) 1.10

Preoperative statins and infectious complications following cardiac surgery. Curr Med Res Opin (2007) 1.09

Experimental acute pancreatitis in PAP/HIP knock-out mice. Gut (2007) 1.08

Computer security in academia-a potential roadblock to distributed annotation of the human genome. Nat Biotechnol (2004) 1.08

Transoral incisionless fundoplication 2.0 procedure using EsophyX™ for gastroesophageal reflux disease. J Gastrointest Surg (2010) 1.08

Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity. PLoS Pathog (2013) 1.07

Diisocyanate asthma and gene-environment interactions with IL4RA, CD-14, and IL-13 genes. Ann Allergy Asthma Immunol (2006) 1.06

Effects of caffeine in non-withdrawn volunteers. Hum Psychopharmacol (2005) 1.06

Rotational muscle flap closure for acute groin wound infections following vascular surgery. Ann Vasc Surg (2004) 1.06

Job strain, effort--reward imbalance, and stress at work: competing or complementary models? Scand J Public Health (2004) 1.06

Role of prasugrel, a novel P2Y(12) receptor antagonist, in the management of acute coronary syndromes. Am J Cardiovasc Drugs (2009) 1.06

The association of psychological factors, physical activity, neuropathy, and quality of life in type 2 diabetes. Biol Res Nurs (2006) 1.04

The effect of time delay on infection in open long-bone fractures: a 5-year prospective audit from a district general hospital. Ann R Coll Surg Engl (2004) 1.04

Nonresolving inflammation in gp91phox-/- mice, a model of human chronic granulomatous disease, has lower adenosine and cyclic adenosine 5'-monophosphate. J Immunol (2009) 1.03

Visual assessment of left ventricular perfusion and function with electrocardiography-gated SPECT has high intraobserver and interobserver reproducibility among experienced nuclear cardiologists and cardiology trainees. J Nucl Cardiol (2002) 1.03

The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail (2006) 1.02

The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg. Atherosclerosis (2008) 1.01

Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother (2008) 1.00

Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study. Clin Chem (2004) 1.00

Surveys of plasma vitellogenin and intersex in male flounder (Platichthys flesus) as measures of endocrine disruption by estrogenic contamination in United Kingdom estuaries: temporal trends, 1996 to 2001. Environ Toxicol Chem (2004) 0.99

Nanoparticles for combination drug therapy. ACS Nano (2013) 0.99

TCR/CD3 mediated stop-signal is decoupled in T-cells from Ctla4 deficient mice. Immunol Lett (2007) 0.99

Effects of late loss of arterial inflow on free flap survival. J Reconstr Microsurg (2002) 0.99

Moxifloxacin and torsade de pointes. Ann Pharmacother (2007) 0.98

Oral focal mucinosis: report of 15 cases and review of the literature. Pathology (2003) 0.98

Benzothiazole derivatives as novel inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1. Mol Cell Endocrinol (2005) 0.98

Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. Clin Pharmacokinet (2002) 0.98

Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ (2012) 0.98

Automated pneumococcal MLST using liquid-handling robotics and a capillary DNA sequencer. Mol Biotechnol (2003) 0.98